¼¿ï´ëº´¿ø ´ëÇѼҾƳ»ºÐºñÇÐȸ ¼Ò¾Æ´ç´¢ ±³À°ÀÚ ¿¬¼ö°Á : 2019-06-15±³À°ÀÏÀÚ : 2019-06-15
±³À°Àå¼Ò : ¼¿ï´ëº´¿ø ÀÇÇבּ¸Çõ½Å¼¾ÅÍ(CMI) ¼¼ºÈ¯¿¬±¸È¦(´ë°´ç)
±³À°ÁÖÁ¦ :
´ëÇѼҾƳ»ºÐºñÇÐȸ ¼Ò¾Æ´ç´¢ ±³À°ÀÚ ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ´ëÇѼҾƳ»ºÐºñÇÐȸ
´ã´çÀÚ : Á¶ÁÖ¿¬
¿¬¶ôó : 02-3471-4268
À̸ÞÀÏ :
kspendo@gmail.com ±³À°Á¾·ù : ¼Ò¾Æû¼Ò³â°ú
Âü¼®¿¹»óÀοø : 120¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-15 09:00~09:50 ¼Ò¾Æ´ç´¢º´ÀÇ Àν¶¸° ÁÖ»ç¿ä¹ý ±è¹Î¼±(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 06-15 09:50~10:40 Utility of CGMS as a measure of glycemic control in children with type 1 diabetes ÀÌÁöÀº(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 06-15 10:40~11:30 Diabetes technology: Continuous Subcutaneous Insulin Infusion À¯Àº°æ(Â÷ÀÇ°úÇдë)
±³À°½Ã°£ 06-15 11:30~12:20 ¼Ò¾Æ ¹× û¼Ò³â±â ´ç´¢º´ÀÇ ½Ä»ç¿ä¹ý ÇÑ»ó¹Ì(¼¿ï¾Æ»êº´¿ø ¿µ¾ç»ç)
±³À°½Ã°£ 06-15 13:30~14:20 Pharmacologic treatment of type 2 diabetes in children and adolescents ±èÀçÇö(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-15 14:20~15:10 Treatment of acute complications in children with type 1 diabetes ¼Áö¿µ(À»ÁöÀÇ´ë)
±³À°½Ã°£ 06-15 15:10~16:00 ¼Ò¾Æ´ç´¢º´ÀÇ ¸¸¼ºÇÕº´Áõ äÇö¿í(¿¬¼¼ÀÇ´ë)
Åä·Ð 06-15 16:00~16:10 Åä·Ð ÃÖÁøÈ£(¿ï»êÀÇ´ë)